DYN EPS Estimates
Dyne Therapeutics, Inc.
$17.44
-$0.55(-3.09%)
43
Overall
60
Value
36
Tech
34
Quality
Market Cap
$3.27B
Volume
49.73K
52W Range
$14.00 - $27.31
Target Price
$34.60
DYN EPS estimates: the consensus estimate for Dyne Therapeutics, Inc.'s current fiscal year is -$3.69 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
DYN EPS Estimates
- EPS estimate, current quarter
- $-0.93
- EPS estimate, next quarter
- $-0.96
- EPS estimate, current year
- $-3.69
- EPS estimate, next year
- $-3.43
- EPS growth, 3-year
- +1.47%
| Fiscal year | EPS |
|---|---|
| 2024 | $-3.37 |
| 2023 | $-3.95 |
| 2022 | $-3.23 |
| 2021 | $-2.93 |
| 2020 | $-4.13 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DYN | $17.44 | -3.1% | 49.73K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |